Latka logo

2024 Revenue

$9.2M(Est.)

Funding

$20M

Team

39

Founded

2013

CancerIQ Revenue & Funding (2024)

CancerIQ generated an estimated $9.2M in annual revenue in 2024. Source: GetLatka estimate

Provider of a Web-based digital application designed to allow oncologists collect genetic information from cancer patients and compare that information against a large database of similar patients. The company's application helps patients and physicians to identify risk factors caused due to cancer, genetics and other oncological problem, enabling doctors to identify high-risk patients and offer preventative treatment.

Last updated

CancerIQ Revenue

In 2024, CancerIQ's revenue reached $9.2M. The company previously reported $5.5M in 2023. Since its launch in 2013, CancerIQ has shown consistent revenue growth.

CancerIQ Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$2M$4M$6M$8M$10M2013201520172019202120232024$0$1.7M$4M$9.2MSource: GetLatka.com
YearMilestoneSource
2024CancerIQ Hit $9.2m revenue in October 2024Estimated
2023CancerIQ Hit $5.5m revenue in November 2023Estimated
2022CancerIQ Hit $4m revenue in March 2022Not recorded
2021CancerIQ Hit $1.7m revenue in April 2021Not recorded
2013Launched with $0 revenue

CancerIQ Valuation, Funding Rounds

CancerIQ has not publicly disclosed its valuation. The company has raised $20M in total funding to date.

CancerIQ has raised $20M in total funding across 3 rounds, most recently a $14M Series B round in 2022.

CancerIQ Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$5M$0.4$10M$0.6$15M$0.8$20M$1$25M201320152017201920212022Source: GetLatka.com
YearRoundAmountValuation% SoldSource
2022Series B$14M--Not recorded
2020Series A$4.8M--Not recorded
2014Convertible Note$1.2M--Not recorded

Founder / CEO

Feyi Ayodele

CEO

Founder and CEO at Cancer IQ Inc. Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse respectively. Her journey with Cancer IQ began in 2012, when Feyi wanted to be more of a participant in the healthcare sector than a bystander. On a family trip to climb Mount Kilimanjaro, she hatched a plan to defer her position at McKinsey and commercialize the work of her mother, a renowned medical oncologist. While at University of Chicago Medicine, Feyi witnessed the most cutting edge clinical care, and identified a number of bottlenecks that constrained patient access to it. In 2013, CancerIQ was born. After recruiting a board of thought leading advisors spearheaded by her mother, she led the product design effort, raised capital, and recruited a team to help her flesh-out the concept. Since conceiving the concept, CancerIQ has garnered support from top accelerator programs, investors, and most importantly - customers. She leads the business development team at CancerIQ, and manages all strategic partnerships. She is a Chicago Booth New Venture Challenge winner, a Rock Health fellow, and winner of 1776’s Global Challenge Cup.

CancerIQ Employees & Team Size

CancerIQ employs approximately 39 people as of 2026, down from 46 in 2023, including 9 sales reps that carry a quota.

CancerIQ Team GrowthReported headcount over time010203040502013201520172019202120232024003939Source: GetLatka.com
YearMilestoneSource
2024Reached 39 employees (December 2024)Not recorded
2024Reached 37 employees (October 2024)Not recorded
2023Reached 46 employees (November 2023)Not recorded
2022Reached 33 employees (November 2022)Not recorded
2022Reached 33 employees (March 2022)Not recorded
2021Reached 20 employees (November 2021)Not recorded
2021Reached 20 employees (April 2021)Not recorded
2020Reached 18 employees (November 2020)Not recorded

Frequently Asked Questions about CancerIQ

What is CancerIQ's revenue?

As of 2024, CancerIQ generated an estimated $9.2M in annual revenue.

Who founded CancerIQ?

CancerIQ was founded by Feyi Ayodele.

When was CancerIQ founded?

CancerIQ was founded in 2013.

Who is the CEO of CancerIQ?

The CEO of CancerIQ is Feyi Ayodele.

How much funding does CancerIQ have?

CancerIQ raised $20M across 3 rounds.

How many employees does CancerIQ have?

As of 2024, CancerIQ had 39 employees.

Where is CancerIQ headquartered?

CancerIQ is headquartered in United States.

Compare CancerIQ to the industry

CancerIQ operates across multiple industries. Browse revenue, funding, and growth data for CancerIQ in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile